BEUDAMED
    FDA Adverse Event Death Summary report: N

    VENATECH LP

    MDR report key: 10101685 · Received May 29, 2020

    Report

    Report Number
    9612452-2020-00018
    Event Type
    Death
    Date Received
    May 29, 2020
    Date of Event
    June 12, 2017
    Report Date
    July 28, 2021
    Manufacturer
    B.BRAUN MEDICAL SAS
    Product Code
    DTK
    UDI-DI
    04038653918164
    PMA / PMN Number
    K010485
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    THE RECENT INFORMATION RECEIVED DOES NOT ALLOW TO ESTABLISH A CAUSALITY LINK BETWEEN THE DEVICE AND THE REPORTED EVENT. B.BRAUN MEDICAL SAS IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THE REPORTED INCIDENT HAS NOT BEEN SUBSTANTIATED BY ANY VERIFIABLE INFORMATION (E.G. FILMS OR MEDICAL RECORDS) THAT COULD BE USED TO INVESTIGATE THE VERACITY OF THE ALLEGED INCIDENT OR RELATION TO THE DEVICE OR PROCEDURE. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR CONCLUSION BY B.BRAUN MEDICAL SAS OR ITS EMPLOYEES THAT THE DEVICE, B. BRAUN MEDICAL SAS, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.

    Description of Event or Problem · 0

    "SUBJECT IS A 69 YEAR OLD FEMALE WITH HISTORY OF HYPERTENSION, SHORTNESS OF BREATH, CURRENT MALIGNANCY, CURRENT AND PAST HISTORY OF RESOLVED BILATERAL DVT LIMITED TO BELOW POPLITEAL VEIN. CONTRAINDICATION TO ANTICOAGULATION DUE TO RECURRENT DVT ON ANTICOAGULANTS; DEVELOPED DVT ON AVASTAN. ON (B)(6) 2016, SUBJECT WAS ADMITTED TO HOSPITAL, CONSENTED, VENATECH® LP VENA CAVA FILTER WAS PLACED WITHOUT COMPLICATION, AND DISCHARGED. ON (B)(6) 2017, SUBJECT UNDERWENT A VENOUS LYSIS FOR LOWER EXTREMITY DVT THAT EXTENDED UP INTO THE INFRARENAL IVC. POST PROCEDURE IN RECOVERY FOR OBSERVATION THE SUBJECT SHOWED PROGRESSIVE ALTERED MENTAL STATUS. SUBJECT MOVED TO CT DEMONSTRATING A LARGE RIGHT TEMPOROPARIETAL INTRAPARENCHYMAL HEMORRHAGE. SUBJECT WAS INTUBATED, AND LATER IN THE EVENING THE FAMILY CHOSE TO EXTUBATE THE SUBJECT AS THEY DID NOT WANT PT TO UNDERGO SURGERY. THE INTRACEREBRAL HEMORRHAGE WAS CONSIDERED EXPECTED, AND NOT RELATED TO THE IVC FILTER OR PROCEDURE. ALSO ON (B)(6) 2017, A CT OF ABDOMEN AND PELVIS WAS OBTAINED FOR POSSIBLE COLITIS WHICH SHOWED EXTENSIVE THROMBUS OF THE IVC EXTENDING FROM THE FILTER DOWN TO THE COMMON ILIAC VEIN. STRANDING CONCERNING FOR THROMBOPHLEBITIS. SUBJECT WAS PLACED ON THERAPEUTIC EXOXAPRIN, VANCOMYCIN AND CEFEPIME. FOLLOW-UP INFORMATION RECEIVED INDICATED THE SUBJECT UNDERWENT AN UNCOMPLICATED PROCEDURE OF A SUCCESSFUL LYSIS AND STENT PLACEMENT ON (B)(6) /2017 AND RECEIVED TPA AND HEPARIN POST PROCEDURE. THE EVENT WAS CONSIDERED RESOLVED WITH SEQUELAE ON (B)(6) 2017, WHEN THE SUBJECT DIED. THE THROMBOPHLEBITIS WAS CONSIDERED EXPECTED, AND POSSIBLY RELATED TO THE FILTER OR PROCEDURE BY THE PI. ADDITIONAL/UPDATED INFORMATION RECEIVED ON 07/07/2021: IN AN EMAIL FROM THE PRESERVE STUDY GROUP: ON (B)(6) 20/17, SUBJECT UNDERWENT A VENOUS LYSIS FOR LOWER EXTREMITY DVT THAT EXTENDED UP INTO THE INFRARENAL IV. POST PROCEDURE IN RECOVERY FOR OBSERVATION THE SUBJECT SHOWED PROGRESSIVE ALTERED MENTAL STATUS. SUBJECT MOVED TO CT DEMONSTRATING A LARGE RIGHT TEMPOROPARIETAL INTRAPARENCHYMAL HEMORRHAGE. SUBJECT WAS INTUBATED, AND LATER IN THE EVENING THE FAMILY CHOSE TO EXTUBATE THE SUBJECT AS THEY DID NOT WANT SUBJECT TO UNDERGO SURGERY."

    Additional Manufacturer Narrative · 1

    BATCH HISTORY REVIEW WE HAVE CHECKED THE MANUFACTURING FILE OF BATCH NR 36895849 WHICH COMPLIES WITH OUR SPECIFICATIONS AND DOES NOT PRESENT ANY DISCREPANCY. NO OTHER COMPLAINT HAS BEEN REPORTED TO US ON THIS BATCH OF VENA CAVA FILTERS RELEASED IN APRIL 2015. INVESTIGATION RESULTS WE DID NOT RECEIVE THE COMPLAINT SAMPLE OR THE X-RAY PICTURES FOR INVESTIGATION. THE INFORMATION AVAILABLE IS INSUFFICIENT. CONCLUSION: WITHOUT CONCRETE ELEMENTS, NO THOROUGH INVESTIGATION CAN BE PERFORMED. THE RELATION BETWEEN THE FILTER AND THE INCIDENT CANNOT BE ESTABLISHED. NO CONCLUSION CAN BE DRAWN ABOUT THE ROOT CAUSE. HOWEVER IT IS WORTH NOTING THAT THIS TYPE OF INCIDENT IS A KNOWN POTENTIAL COMPLICATION OF THE IMPLANTATION OF VENA CAVA FILTER, WELL DOCUMENTED IN THE LITERATURE THE COMPLAINT RATE FOR THIS TYPE OF INCIDENT IS LOW. NO CORRECTIVE ACTION IS ENVISAGED. IF NEW ELEMENTS BECOME AVAILABLE IN THE FUTURE, WE WILL REOPEN THIS COMPLAINT.

    Description of Event or Problem · 1

    SUBJECT IS A (B)(6) YEAR OLD FEMALE WITH HISTORY OF HYPERTENSION, SHORTNESS OF BREATH, CURRENT MALIGNANCY, CURRENT AND PAST HISTORY OF RESOLVED BILATERAL DVT LIMITED TO BELOW POPLITEAL VEIN. CONTRAINDICATION TO ANTICOAGULATION DUE TO RECURRENT DVT ON ANTICOAGULANTS; DEVELOPED DVT ON AVASTAN. ON (B)(6) 2016, SUBJECT WAS ADMITTED TO HOSPITAL, CONSENTED, VENATECH® LP VENA CAVA FILTER WAS PLACED WITHOUT COMPLICATION, AND DISCHARGED. ON (B)(6) 2017, SUBJECT UNDERWENT A VENOUS LYSIS FOR LOWER EXTREMITY DVT THAT EXTENDED UP INTO THE INFRARENAL IVC. POST PROCEDURE IN RECOVERY FOR OBSERVATION THE SUBJECT SHOWED PROGRESSIVE ALTERED MENTAL STATUS. SUBJECT MOVED TO CT DEMONSTRATING A LARGE RIGHT TEMPOROPARIETAL INTRAPARENCHYMAL HEMORRHAGE. SUBJECT WAS INTUBATED, AND LATER IN THE EVENING THE FAMILY CHOSE TO EXTUBATE THE SUBJECT AS THEY DID NOT WANT PT TO UNDERGO SURGERY. THE INTRACEREBRAL HEMORRHAGE WAS CONSIDERED EXPECTED, AND NOT RELATED TO THE IVC FILTER OR PROCEDURE. ALSO ON (B)(6) 2017, A CT OF ABDOMEN AND PELVIS WAS OBTAINED FOR POSSIBLE COLITIS WHICH SHOWED EXTENSIVE THROMBUS OF THE IVC EXTENDING FROM THE FILTER DOWN TO THE COMMON ILIAC VEIN. STRANDING CONCERNING FOR THROMBOPHLEBITIS. SUBJECT WAS PLACED ON THERAPEUTIC EXOXAPRIN, VANCOMYCIN AND CEFEPIME. FOLLOW-UP INFORMATION RECEIVED INDICATED THE SUBJECT UNDERWENT AN UNCOMPLICATED PROCEDURE OF A SUCCESSFUL LYSIS AND STENT PLACEMENT ON (B)(6) 2017 AND RECEIVED TPA AND HEPARIN POST PROCEDURE. THE EVENT WAS CONSIDERED RESOLVED WITH SEQUELAE ON (B)(6) 2017, WHEN THE SUBJECT DIED. THE THROMBOPHLEBITIS WAS CONSIDERED EXPECTED, AND POSSIBLY RELATED TO THE FILTER OR PROCEDURE BY THE PI.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    566315 VENATECH LP VENA CAVA FILTER DTK B.BRAUN MEDICAL SAS 31335 36895849 04038653918164

    Patients

    Seq Age Sex Outcome Treatment
    1 70 YR Death| L| R